期刊文献+

中西药治疗冠心病研究概况 被引量:1

Research Progress of Traditional Chinese Medicine and Western Medicine in the Treatment Coronary Heart Disease
下载PDF
导出
摘要 西药治疗冠心病收效尚可,但长期服用对肝肾毒副作用较大,并且不可逆。中医药对冠心病辨证分型及其中成药、中药注射液等治疗可以从多靶位多角度机制来实现疗效,且毒副反应低。但临床仍以汤剂为主,使用不便,难以用于急症治疗和抢救。多以单味药和单味药有效成分为主,复方研究开发较少。今后应重点创新给药途径及剂型改革。从大量的临床报道来看,中医药以及中西医结合冠心病防治都有着较好疗效。 At present, all kinds of western medicine are effective satisfaction of various types of coronary heart disease, but the western long - term use of liver and kidney toxic side effects, and irreversible. TCM syndrome type of coronary heart disease and Chinese medicine, Chinese medicine injections and other treat-ments can target multiple perspectives from multiple mechanisms to achieve efficacy, and toxicity is low. But still the decoction of the main clinical, inconvenient to use, it is difficult for emergency treatment and rescue. More than a single herb and single herb -based active ingredients, research and development of small com-pound. The future route of administration should focus on innovation and the formulation of reform. View from a large number of clinical reports, Traditional Chinese medicine and Western medicine combined with preven- tion of coronary heart disease have a better effect.
出处 《实用中医内科杂志》 2012年第2期89-91,共3页 Journal of Practical Traditional Chinese Internal Medicine
关键词 冠心病 胸痹 厥心痛 中药注射液 冠心病西医治疗 复方丹参滴丸 中医药治疗 综述 Coronary heart disease Chest Jue heartache Chinese medicine injection Western medi-cine treatment of coronary heart disease CSDP Traditional Chinese medicine Review
  • 相关文献

参考文献13

二级参考文献15

  • 1雷正一,王硕仁.黄芪对心血管系统的作用[J].中国中西医结合杂志,1993,13(7):443-446. 被引量:275
  • 2徐庆有,李学信.灯盏细辛注射液对高粘滞血症病人血液粘度的影响[J].新药与临床,1995,14(4):233-234. 被引量:77
  • 3陈国伟 郑宗锷.现代心脏内科学[M].湖南科学技术出版社,1996.908-921.
  • 4秦腊梅.党参、黄芪补益心气作用的研究[J].中药药理与临床,1987,(3):31-31.
  • 5陈可冀.心脑血管疾病研究[M].上海:上海科学技术出版社,1998.344.
  • 6范礼理 曾贵云 等.葛根的药理研究Ⅱ:葛根黄酮对犬冠状脉循环、心脏血流动力学和心肌代谢的作用[J].中华医学杂志,1975,55(10):724-724.
  • 7秦腊梅 阎艳芳 等.补气中药党参、黄芪对血小板钙调蛋白尖性的影响[J].中药药理与临床,1988,4(3):25-25.
  • 8李学信 徐庆有.云南灯盏花注射液降血脂的临床观察[J].临床荟萃,1994,19:21-22.
  • 9宋哲林.川芎嗪可防治冠脉介入治疗后再狭窄[J].中国医学论坛报,2000,(3):20-20.
  • 10国际心脏病学会和协会及世界卫生组织临床命名标准联合专题组.Circu1ation[R].,1979.59-60.

共引文献84

同被引文献27

  • 1陈伯钧,潘宗奇,苏学旭.高血脂症的中西医结合治疗进展[J].现代中西医结合杂志,2005,14(21):2882-2884. 被引量:6
  • 2陈益石,陈润东.中西药联用利弊分析及规范化使用建议[J].湖南中医药大学学报,2006,26(5):9-10. 被引量:5
  • 3Salim Yusuf,Sonia Anand. Deciphering the Causes of Cardiovascular and Other Complex Diseases in Populations : Achievements, Challenges, Op- portunities, and Approaches [ J ]. Progress in Cardiovascular Diseases, 2010,53( 1 ) :62.
  • 4Juhan F. Thayer ,Shelby S. Yamammoto,Jos F. Brosschot. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors[ J]. International Journal of Cardiology,2010,141 (2) : 122.
  • 5Robert H, Momtaz Wassef, Alan Chair, et al. Prevention conference Ⅵ: Diabetes and cardiovascular disease writing group Ⅱ:Pathogenesis of ath- erosclerosis in diabetes [ C ]. AHA Conference Proceedings,2002 : 1 - 4.
  • 6刘惠萍,吴智松.中西药联用是中西医结合的具体体现[C].第三届中西医结合大会论文摘要集,2007:742.
  • 7梁钊明,盛小刚.慢性心力衰竭中西医结合疾病管理体系的构建[D].广州:广州中医药大学,2012:3.
  • 8周顺,滕树忠.中西药联用对临床药效的影响[J].中国现代医生,2008,46(8):100-101. 被引量:11
  • 9王健.中西医结合治疗频发性室性早搏45例观察[J].实用中医药杂志,2008,24(12):780-780. 被引量:4
  • 10罗国安,梁琼麟,刘清飞,李雪,王义明.复方药物研发创新体系展望[J].世界科学技术-中医药现代化,2009,11(1):3-10. 被引量:21

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部